Toufen, Taiwan

Mei-Chih Wang

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Industrial Technology Research Institute. Active years: 2007-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mei-Chih Wang. Retrieved from https://idiyas.com/inventor/mei-chih-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Mei-Chih Wang

Introduction

Mei-Chih Wang is a notable inventor based in Toufen, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of methods and sequences that enhance the growth and specificity of liver cells. With a total of 3 patents to his name, Wang's work is recognized for its potential applications in medical research and treatment.

Latest Patents

One of Wang's latest patents is titled "Liver specific chimeric regulatory sequence and use thereof." This invention relates to a chimeric regulatory sequence that exhibits liver cell specificity. The sequence includes a proximal regulatory sequence and a distal enhancer 5' flanking region of the human α-fetoprotein (AFP) gene. This innovative regulatory sequence is particularly useful for purifying specific lineages, such as liver cells, from other cell types.

Another significant patent by Wang is "Methods for culturing human embryonic stem cells." This invention discloses a method aimed at improving the growth and survival of single human embryonic stem cells. The method involves obtaining a single undifferentiated human embryonic stem (HES) cell, mixing it with an extracellular matrix (ECM) to encompass the cell, and inoculating the mixture onto feeder cells with a nutrient medium in a controlled growth environment. This approach allows single cells to survive, proliferate, and grow in vitro.

Career Highlights

Mei-Chih Wang is affiliated with the Industrial Technology Research Institute, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on regenerative medicine and cell therapy.

Collaborations

Wang collaborates with several talented individuals in his field, including Hui-Ti Lin and Chin-Yu Lin. Their combined expertise contributes to the success of their research initiatives.

Conclusion

Mei-Chih Wang's contributions to biotechnology through his innovative patents highlight his role as a leading inventor in the field. His work not only advances scientific understanding but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…